Health Care & Life Sciences » Pharmaceuticals | Shionogi & Co. Ltd.

Shionogi & Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
289,717
273,991
309,973
338,890
344,667
363,721
Cost of Goods Sold (COGS) incl. D&A
77,993
82,189
74,758
77,777
73,911
54,880
Gross Income
211,724
191,802
235,215
261,113
270,756
308,841
SG&A Expense
148,167
141,436
143,808
152,934
155,537
170,303
EBIT
63,557
50,366
91,407
108,179
115,219
138,538
Unusual Expense
4,558
2,314
6,822
3,275
1,847
17,609
Non Operating Income/Expense
6,383
33,774
12,301
17,205
23,399
47,605
Interest Expense
888
274
207
220
557
581
Pretax Income
64,869
82,051
97,452
122,695
137,378
170,343
Income Tax
22,937
37,833
30,823
39,084
28,589
37,037
Consolidated Net Income
41,932
44,218
66,629
83,610
108,788
133,306
Net Income
41,831
44,060
66,687
83,878
108,866
132,759
Net Income After Extraordinaries
41,831
44,060
66,687
83,878
108,866
132,759
Net Income Available to Common
41,831
44,060
66,687
83,879
108,866
132,759
EPS (Basic)
124.91
132.67
204.83
259.87
342.71
424.31
Basic Shares Outstanding
335
332
326
323
318
313
EPS (Diluted)
124.85
132.04
201.70
255.87
337.43
420.67
Diluted Shares Outstanding
335
334
331
328
323
316
EBITDA
79,182
66,016
107,275
124,519
134,226
157,737
Non-Operating Interest Income
376
500
774
808
1,167
2,393
Minority Interest Expense
101
158
58
268
78
547

About Shionogi & Co.

View Profile
Address
3-1-8 Dosho-machi
Osaka Osaka 541
Japan
Employees -
Website http://www.shionogi.co.jp
Updated 07/08/2019
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.